ICMR removes ceiling of Rs 4,500 on Coronavirus Tests

▴ ICMR removes ceiling of Rs 4,500 on Coronavirus Tests
Private Labs are free to fix the charges of COVID-19 tests

The Indian Council of Medical Research has removed the price cap of Rs 4,500 for the real-time polymerase chain reaction (RT-PCR) test used to detect COVID-19, asking states and UTs to negotiate with private labs to fix "mutually agreeable" rates for the test.


In a letter to the state chief secretaries on Monday, ICMR Director General (D-G) Dr Balram Bhargava said the COVID-19 diagnostic supplies are stabilising because of the indigenous production of the kits."In this backdrop and keeping in view the evolving prices of testing commodities, the earlier suggested upper ceiling of Rs 4500 vide letter dated March 17, may not be applicable now," he said."Therefore, all state governments/UT administrations are advised to negotiate with private labs and fix up mutually agreeable prices for samples being sent by the government and also for private individuals desirous of testing by these labs," Bhargava said in the letter.

He said at the beginning of the COVID-19 pandemic there was a global crisis of testing kits and reagents as India was heavily reliant on imported products for molecular detection of viruses. As such in mid-march, no rates for RT-PCR tests for coronavirus were available for reference in the country.

"Keeping in view the cost of imported kits and efforts involved in carrying out the test, the ICMR suggested the upper limit of a single test at Rs 4500," the letter said.

There are 428 government and 182 private labs for COVID-19 testing across all states and UTs in the country.

"Now testing supplies are also stabilizing and many of you have started procuring such kits from the local market. Due to varied options of testing materials/kits, including indigenous ones, the prices are becoming competitive and undergoing reduction," Bhargava said.

The ICMR D-G said concerted efforts have been made to ramp up the testing capacity in the country.

"In this intervening period all efforts have been made to facilitate local companies by handholding and promoting them to locally manufacture swabs, viral transport media, and RNA extraction kits. Further, indigenous diagnostic kits are being approved on a fast track basis for RT-PCR testing," he said in the letter.

PTI

Tags : #ICMR #CoronavirusTest #RTPCR #BalramBhargava

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024